SARS-CoV-2 reinfection and implications for vaccine development

Publication Name : Human Vaccines and Immunotherapeutics

DOI : 10.1080/21645515.2020.1830683

Date : 2020


Type
Journal
ISSN
21645515
Volume
16
Page
3061-3073